Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer
Open Access
- 13 October 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (23) , 5963-5976
Abstract
Colorectal adenocarcinoma is a leading cause of death worldwide, and immune infiltration in colorectal tumors has been recognized recently as an important pathophysiologic event. In this context, tumor-associated macrophages (TAM) have been related to chemoresistance to 5-fluorouracil (5-FU), the first-line chemotherapeutic agent used in treating colorectal cancers. Nevertheless, the details of this chemoresistance mechanism are still poorly elucidated. In the current study, we report that macrophages specifically overexpress dihydropyrimidine dehydrogenase (DPD) in hypoxia, leading to macrophage-induced chemoresistance to 5-FU via inactivation of the drug. Hypoxia-induced macrophage DPD expression was controlled by HIF2α. TAMs constituted the main contributors to DPD activity in human colorectal primary or secondary tumors, while cancer cells did not express significant levels of DPD. In addition, contrary to humans, macrophages in mice do not express DPD. Together, these findings shed light on the role of TAMs in promoting chemoresistance in colorectal cancers and identify potential new therapeutic targets.Significance: Hypoxia induces HIF2α-mediated overexpression of dihydropyrimidine dehydrogenase in TAMs, leading to chemoresistance to 5-FU in colon cancers.Keywords
All Related Versions
Funding Information
- Inserm and La ligue nationale contre le cancer
- APMC Fondation
- Agir pour les Maladies Chroniques
- International Training Network
- European Union's Horizon 2020
- Marie Skłodowska-Curie (812772)
- ERiCAN program of Fondation MSD-Avenir (DS-2018-0015)
This publication has 43 references indexed in Scilit:
- Chemoprevention, chemotherapy, and chemoresistance in colorectal cancerDrug Metabolism Reviews, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancerGenes & Development, 2011
- Leukocyte composition of human breast cancerProceedings of the National Academy of Sciences of the United States of America, 2011
- The role of myeloid cells in the promotion of tumour angiogenesisNature Reviews Cancer, 2008
- Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapyAnnals of Oncology, 2008
- Genevestigator V3: A Reference Expression Database for the Meta‐Analysis of TranscriptomesAdvances in Bioinformatics, 2008
- Inter‐individual variability in levels of human microsomal protein and hepatocellularity per gram of liverBritish Journal of Clinical Pharmacology, 2003
- Immunohistochemical Demonstration of Dihydropyrimidine Dehydrogenase in Normal and Cancerous TissuesACTA HISTOCHEMICA ET CYTOCHEMICA, 2003
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989